GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Up 634.6% in January

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a significant increase in short interest in January. As of January 30th, there was short interest totaling 234,255 shares, an increase of 634.6% from the January 15th total of 31,889 shares. Based on an average daily volume of 1,698,025 shares, the days-to-cover ratio is currently 0.1 days. Approximately 23.3% of the shares of the company are short sold. Approximately 23.3% of the shares of the company are short sold. Based on an average daily volume of 1,698,025 shares, the days-to-cover ratio is currently 0.1 days.

GlucoTrack Price Performance

Shares of GCTK traded up $0.04 during midday trading on Tuesday, reaching $1.79. The stock had a trading volume of 52,506 shares, compared to its average volume of 949,163. The firm’s 50 day moving average price is $3.93 and its 200-day moving average price is $5.32. The company has a market capitalization of $1.81 million, a P/E ratio of -0.05 and a beta of 0.32. GlucoTrack has a 52 week low of $1.52 and a 52 week high of $40.78. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.53 and a quick ratio of 1.53.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of GlucoTrack in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, GlucoTrack has a consensus rating of “Sell”.

Hedge Funds Weigh In On GlucoTrack

An institutional investor recently raised its position in GlucoTrack stock. Bank of America Corp DE lifted its holdings in GlucoTrack, Inc. (NASDAQ:GCTK) by 102,125.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,089 shares of the company’s stock after purchasing an additional 4,085 shares during the period. Bank of America Corp DE owned about 0.85% of GlucoTrack worth $25,000 at the end of the most recent reporting period. Institutional investors own 10.92% of the company’s stock.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.